From virtual to real screening for D3 dopamine receptor ligands

被引:21
作者
Byvatov, E
Sasse, BC
Stark, H
Schneider, G
机构
[1] Univ Frankfurt, Inst Organ Chem & Chem Biol, Fachbereich Chem & Pharm Wissensch, Beilstein Endowed Chair Cheminformat, D-60439 Frankfurt, Germany
[2] Univ Frankfurt, Inst Pharmaceut Chem, D-60439 Frankfurt, Germany
关键词
bioinformatics; drug discovery; G protein-coupled receptors; pharmacophores; screening; similarity;
D O I
10.1002/cbic.200400400
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Even in the absence of receptor-structure information, iterative virtual screening cycles with support vector machines (SVM) offer a rapid way to identify novel leads with minimal experimental effort. First, an SVM is trained for prediction of D3 receptor-selective ligands. Based on the prediction of this virtual filter, compounds are tested for binding affinity at D2 and D3 receptors. Second, a similarity search is performed with the most promising candidate from round one. Four out of five compounds from the final hit list exhibited nanomolar affinity at the D 3 receptor including a novel scaffold structure. The Ki value of the best molecule (1) was 40±6 nM. © 2005 Wiley-VCH Verlag GmbH & Co. KGaA.
引用
收藏
页码:997 / 999
页数:3
相关论文
共 19 条
[11]   Development of novel 1,2,3,A-tetrahydroisoquinoline derivatives and closely related compounds as potent and selective dopamine D3 receptor ligands [J].
Mach, UR ;
Hackling, AE ;
Perachon, S ;
Ferry, S ;
Wermuth, CG ;
Schwartz, JC ;
Sokoloff, P ;
Stark, H .
CHEMBIOCHEM, 2004, 5 (04) :508-518
[12]  
Mokrosz MJ, 2001, ARCH PHARM, V334, P25, DOI 10.1002/1521-4184(200101)334:1<25::AID-ARDP25>3.0.CO
[13]  
2-8
[14]  
Mokrosz MJ, 1999, ARCH PHARM, V332, P373, DOI 10.1002/(SICI)1521-4184(199911)332:11<373::AID-ARDP373>3.3.CO
[15]  
2-C
[16]   Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist [J].
Pilla, M ;
Perachon, S ;
Sautel, F ;
Garrido, F ;
Mann, A ;
Wermuth, CG ;
Schwartz, JC ;
Everitt, BJ ;
Sokoloff, P .
NATURE, 1999, 400 (6742) :371-375
[17]  
SCHNEIDER G, 2004, CHEMOGENOMICS DRUG D, P341
[18]   MOLECULAR-CLONING AND CHARACTERIZATION OF A NOVEL DOPAMINE RECEPTOR (D3) AS A TARGET FOR NEUROLEPTICS [J].
SOKOLOFF, P ;
GIROS, B ;
MARTRES, MP ;
BOUTHENET, ML ;
SCHWARTZ, JC .
NATURE, 1990, 347 (6289) :146-151
[19]   CLONING OF THE GENE FOR A HUMAN DOPAMINE D4-RECEPTOR WITH HIGH-AFFINITY FOR THE ANTIPSYCHOTIC CLOZAPINE [J].
VANTOL, HHM ;
BUNZOW, JR ;
GUAN, HC ;
SUNAHARA, RK ;
SEEMAN, P ;
NIZNIK, HB ;
CIVELLI, O .
NATURE, 1991, 350 (6319) :610-614